Evidence map›Paper›PMID 37455998›Full record

ArticleHeliyon2023

lncRNA XIST inhibition promotes M2 polarization of microglial and aggravates the spinal cord injury via regulating miR-124-3p / IRF1 axis.

Jin Yang, Zhiqiang Gong, Junjie Dong, Hangchuan Bi, Bing Wang, Kaili Du, Chunqiang Zhang, Lingqiang Chen

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
10.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. LncRNAs Orchestrating Neuroinflammation: A Comprehensive Review.Cellular and molecular neurobiology · 2025
    Review
  11. NcRNAs: a potential treatment for spinal cord injury.Frontiers in cellular neuroscience · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jin YangDepartment of Orthopaedics, First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China.
Zhiqiang GongDepartment of Orthopaedics, First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China.
Junjie DongDepartment of Orthopaedics, First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China.
Hangchuan BiDepartment of Orthopaedics, First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China.
Bing WangDepartment of Orthopaedics, First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China.
Kaili DuDepartment of Orthopaedics, First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China.
Chunqiang ZhangDepartment of Orthopaedics, First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China.
Lingqiang ChenDepartment of Orthopaedics, First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China.
First Affiliated Hospital of Kunming Medical University · CNKunming Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinal cord injury (SCI) has a high disability rate and mortality rate. Recently, LncRNA XIST has been found to be involved in the regulation of inflammatory responses. Therefore, we aimed to investigate the role of XIST in the occurrence and development of SCI and the specific regulation mechanism.

Indexed as

IRF1lncRNA XISTMicrogliamiR-124–3pPolarizationSpinal cord injury

Identifiers

PMID37455998
PMCPMC10344764
OpenAlexW4382933777

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.